SynerFuse, Inc., a privately held, clinical-stage medical device company focused on the development of a novel neuromodulation therapy concept for the treatment of chronic back pain, today announced that the U.S. Patent & Trademark Office (USPTO) has issued U.S. Patent Number 11,247,046 entitled Methods and Systems for Implanting a Neuromodulation System at a Surgically Open…
ԻՆՉ Է ՀԱՆԵԼ ԱՅՍ ՀՈԴՎԱԾԻՑ.
- , a privately held, clinical-stage medical device company focused on the development of a novel neuromodulation therapy concept for the treatment of chronic back pain, today announced that the U.
- Patent Number 11,247,046 entitled Methods and Systems for Implanting a Neuromodulation System at a Surgically Open….
- eTurboNews հոդվածները նախատեսված են միայն բաժանորդների համար: